North America to Dominate Global Oral Drug Delivery Market During the Forecast Period
Increasing use of biological
drugs is expected to drive the growth of global oral drug delivery market
during the forecast period.
According
to TechSci Research report, “Global Oral
Drug Delivery Market, By Formulation (Tablets, Capsules, Drops, Liquid or
Syrup), By Type (Controlled Release, Orodispersible Tablets, Others), By
Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal,
Respiratory, Cardiovascular, Others), By End User (Hospitals, Ambulatory
Surgical Centres, Diagnostic Centres, Clinics, Others), By Region, By Company,
Competition, Forecast & Opportunities, 2026”, Global
oral drug delivery market is expected to witness a CAGR of around 7% over the
forecast period. Mounting demand for effective drug delivery mechanisms is one of the major factors accounting
for the growth of global oral drug delivery market. Moreover, ongoing
technological advancements is expected to bode well for the growth of global
oral drug delivery market through the forecast period. In addition to this, surging
use of biological drugs is positively influencing the growth of global oral
drug delivery market in the years to come. Along with this, supportive
government funding is positively contributing to the market growth in the next
5 years. Due to the outbreak of corona virus globally, there is a sudden rise
in the demand for pharmaceutical drugs largely in infectious application, which
is further bolstering the market growth. However, there are certain factors
that might act as major impediments to the growth of global oral drug delivery
market during the forecast period such as risk associated with the side effects
of drugs and needle stick injuries.
Browse XX market data Tables and XX Figures
spread through XXX
Pages and an in-depth TOC on" Global Oral Drug Delivery Market
"
https://www.techsciresearch.com/report/oral-drug-delivery-market/7236.html
Global
oral drug delivery market can be segmented based on formulation, type, therapy area, end
user, company, and region. Considering the end user, the market is
fragmented into hospitals, ambulatory surgical centers, diagnostic centers,
clinics, others. The hospital segment
dominated the global oral drug delivery market until 2020 and is further
anticipated to maintain its dominance during the forecast period as well. This
is because of rising occurrence of diseases across the globe which in turn
increases the need for treatment at hospitals utilizing drug delivery
technology. Besides, ambulatory surgical centers are expected to grow at a high
pace in the next 5 years as they deploy drug delivery technology for
administering the drugs to patients on an immediate basis or under emergency
conditions.
Novartis
AG, Biocon Ltd., NovoNordisk A/S, F.Hoffmann-La Roche Ltd., Bayer AG,
Emishphere Technologies Inc., Enteris Biopharma Inc., Merrion Pharmaceuticals
Plc., Amgen Inc., Pfizer Inc., among others are the leading players operating in
global oral drug delivery market. The leading players are adopting several
growth strategies to enhance the market scenario of oral drug delivery. Other
competitive strategies include product launches; mergers & acquisitions;
agreements, partnerships, and collaborations; and expansions to diverse their
product portfolio in order to strengthen their market position.
Download
sample report @
https://www.techsciresearch.com/sample-report.aspx?cid=7236
customers can also
request for 10% free customization on this report.
North America is forecasted to dominate the global oral drug delivery market
in the next 5 years on account of upsurge in the number of pharmaceutical
companies in the region. Furthermore, increasing incidence of chronic diseases including
cancer, respiratory allergies, and diabetes are also contributing to the
growing trend. Asia pacific region is forecasted to register highest growing
CAGR over the years to come which can be attributed to rising focus to boost
biologic sector coupled with increasing technological advancements in oral drug
delivery technology.”, said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“Global Oral Drug Delivery Market, By Formulation
(Tablets, Capsules, Drops, Liquid or Syrup), By Type (Controlled Release,
Orodispersible Tablets, Others), By Therapy Area (Oncology, Musculoskeletal,
Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others), By End User
(Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others), By
Region, By Company, Competition, Forecast & Opportunities, 2026” has evaluated the future growth potential of global oral
drug delivery market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global oral drug delivery
market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]